Determination of antiretroviral drugs for buyers' club in Switzerland using capillary electrophoresis methods.


Journal

Electrophoresis
ISSN: 1522-2683
Titre abrégé: Electrophoresis
Pays: Germany
ID NLM: 8204476

Informations de publication

Date de publication:
03 2021
Historique:
received: 27 07 2020
revised: 06 11 2020
accepted: 01 12 2020
pubmed: 8 12 2020
medline: 24 12 2021
entrez: 7 12 2020
Statut: ppublish

Résumé

Human immunodeficiency virus-acquired immunodeficiency syndrome continues to be a major global public health issue, having claimed almost 33 million lives to date. Due to the high cost of antiretroviral treatment, access to these drugs remains difficult for vulnerable populations, such as migrants and people living in prisons, who often do not have health insurance. These factors lead to poorer health outcomes and higher transmission rates. The personal importation scheme for unapproved generics from foreign countries is one option to access affordable human immunodeficiency virus treatment. However, the risk of importing falsified medicine remains high, and the quality control of unapproved drugs is lacking. In this context, three CE methods for the analysis of nine antiviral drugs found in commercial pharmaceutical formulations were evaluated. The selected compounds were emtricitabine, tenofovir disoproxil, tenofovir alafenamide, rilpivirine, efavirenz, raltegravir, dolutegravir, abacavir, and lamivudine. The developed methods were successfully applied to determine the active pharmaceutical ingredients of commercial formulations and unapproved generics. The quality control of unapproved generics by CE is an attractive approach due to its good standard of quality, low cost, ecofriendliness, and ease of implementation.

Identifiants

pubmed: 33284492
doi: 10.1002/elps.202000216
doi:

Substances chimiques

Anti-Retroviral Agents 0
Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

708-718

Informations de copyright

© 2020 Wiley-VCH GmbH.

Références

Warnke, D., Barreto, J., Temesgen, Z., J. Clin. Pharmacol. 2007, 47, 1570-1579.
York, A., Nat. Rev. Microbiol. 2019, 399.
World Health Organization, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection, World Health Organization, Geneva 2016.
Jackson, Y., Paignon, A., Wolff, H., Delicado, N., PLoS One 2018, 13, e0201313.
Nathalie, V., Alexandra, C., Samia, H., Yves, J., Francesco, N., Arnaud, P., Hans, W., Swiss Med. Wkly. 2018, 148, w14649.
Garcia, A., Moore Boffi, S., Gayet-Ageron, A., Vernaz, N., PLoS One 2019, 14, e0223649.
Clark, F., Lancet 2015, 386, 1327-1328.
Nicol, D., Owoeye, O., Bull. World Health Organ. 2013, 91, 533-539.
World Trade Organization, Declaration on the TRIPS Agreement and Public Health, World Trade Organization, Geneva 2001.
World Health Organization, World Health Organization Model List of Essential Medicines, 21st List, 2019, World Health Organization, Geneva 2019.
Elliott, R., Bonin, M.-H., Devine, C., Les Brevets, Le Droit Commercial International et l'accès Aux Médicaments Essentiels, 3rd Ed., Sage Collection, Montréal 2003.
Kandagal, P. B., Manjunatha, D. H., Seetharamappa, J., Kalanur, S. S., Anal. Lett. 2008, 41, 561-570.
Barkil, M. El, Gagnieu, M. C., Guitton, J., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 854, 192-197.
Ramaswamy, A., Arul Gnana Dhas, A. S., Arab. J. Chem. 2018, 11, 275-281.
Coulier, L., Gerritsen, H., van Kampen, J. J. A., Reedijk, M. L., Luider, T. M., Osterhaus, A. D. M. E., Gruters, R. A., Brüll, L., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879, 2772-2782.
Jullien, V., Tréluyer, J. M., Pons, G., Rey, E., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2003, 785, 377-381.
Sparidans, R. W., Crommentuyn, K. M. L., Schellens, J. H. M., Beijnen, J. H., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2003, 791, 277-233.
Anandgaonkar, V., Gupta, A., Kona, S., Talluri, M. V. N. K., J. Pharm. Biomed. Anal. 2015, 107, 175-185.
Pendela, M., Kahsay, G. W., Van Den Mooter, G., Baert, L., Hoogmartens, J., Adams, E., Chromatographia 2011, 73, 439-445.
Bhirud, C. H., Hiremath, S. N., J. Pharm. Res. 2013, 7, 157-161.
Al-Johar, H. I., Maher, H. M., Al-Zoman, N. Z., Al-Shammary, D. J., Al-Showiman, H., Acta Chromatogr. 2017, 29, 469-476.
Marini, R. D. G. E. a., Kindenge, J. M., De María Lourdes Montes, A. J. A., Debrus, B., Lebrun, P., Mantanus, J., Ziemons, E., Rohrbasser, C., Rudaz, S., Hubert, P., Chim. Oggi 2010, 28, 10-14.
Marini, R. D., Rozet, E., Montes, M. L. A., Rohrbasser, C., Roht, S., Rhème, D., Bonnabry, P., Schappler, J., Veuthey, J. L., Hubert, P., Rudaz, S., J. Pharm. Biomed. Anal. 2010, 53, 1278-1287.
Agrofoglio, L. A., Cahours, X., Tran, T. T., Dessans, H., Kieda, C., Morin, P., Nucleosides Nucleotides Nucleic Acids 2001, 20, 375-381.
Pereira, E. A., Micke, G. A., Tavares, M. F. M., J. Chromatogr. A 2005, 1091, 169-176.
Fan, B., Stewart, J. T., J. Capill. Electrophor. Microchip Technol. 2002, 7, 103-106.
Sekar, R., Azhaguvel, S., Chromatographia 2008, 67, 389-398.
Sekar, R., Azhaguvel, S., J. Pharm. Biomed. Anal. 2005, 39, 653-660.
Gras, A., Yegles, M., Karasi, J. C., Schmit, J. C., Seguin-Devaux, C., Schneider, S., Ann. Toxicol. Anal. 2013, 24, 177-183.
Checa, A., Oliver, R., Hernández-Cassou, S., Saurina, J., Anal. Chim. Acta 2009, 647, 1-13.
Gumustas, M., Caglayan, M. G., Onur, F., Ozkan, S. A., Biomed. Chromatogr. 2018, 32, e4158.
Wieczorek, M., Rengevicova, S., Świt, P., Woźniakiewicz, A., Kozak, J., Kościelniak, P., Talanta 2017, 170, 165-172.
Reig, F. B., Falco, P. C., Analyst 1988, 113, 1011-1016.
Campíns-Falcó, P., Verdú-Andrés, J., Bosch-Reig, F., Molíns-Legua, C., Anal. Chim. Acta 1995, 302, 323-333.
Scriba, G., Altria, K., LC GC Eur. 2009, 22, 420-430.
Hădărugă, N. G., Bandur, G. N., David, I., Hădărugă, D. I., Environ. Chem. Lett. 2019, 17, 349-373.
Rudaz, S., Calleri, E., Geiser, L., Cherkaoui, S., Prat, J., Veuthey, J. L., Electrophoresis 2003, 24, 2633-2641.
Rudaz, S., Veuthey, J. L., Desiderio, C., Fanali, S., J. Chromatogr. A 1999, 846, 227-237.

Auteurs

Nicolas Guichard (N)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Switzerland.

Elena Tobolkina (E)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Switzerland.

Lamyae El Morabit (L)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Switzerland.

Pascal Bonnabry (P)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Switzerland.
Geneva University Hospitals, Geneva, Switzerland.

Nathalie Vernaz (N)

Geneva University Hospitals, Geneva, Switzerland.

Serge Rudaz (S)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH